Understanding about autism will get a boost as universities, charities and expert institutions from 14 European countries come together in a major new programme. Autism Spectrum Disorders in Europe(ASDEU) has been funded by the European Commissionto research autism diagnosis, prevalence and interventions and to improve care and support for peoplewith autism.
Autism Spectrum Disorders in Europe (ASDEU) is a three-year programme run by a consortium of 20 groups from 14 countries. ASDEU has received 2.1 million euros from theDirectorate-General of Health and Consumers of theEuropean Commission (DG-SANCO) to increase understanding of and improve responses to autism. It will:
- study the prevalence of autism in 12 countries in theEuropean Union;
- analyse the economic and social costsof autism;
- review existing arrangements and develop proposals for early detection programmes;
- train professionals;
- validate biomarkers for the disorder;
- improve understanding of diagnosis, comorbidity, and effective care and support for adults and senior citizenswith autism.
In the field of public health, ASDEU will also collaborate with European Autism Interventions – A Multicentre Studyfor Developing New Medications (EU-AIMS) http://www.eu-aims.eu to improve quality of life and prognosis for people with autism.
The ASDEU consortium partners are:
The project lead, Manuel Posada, Director of the Rare Diseases Research Institute – ISCIII, Spain, will be supported in his management role by the ISCIII and the Spanish Foundation for Health and International Cooperation. Joaquin Fuentes, from Policlínica Gipuzkoa in Donostia/San Sebastián, Spain, will act as Scientific Advisor tothe ASDEU project.
The project will officially begin on February 15th, 2015.